Exercise-induced myokine FNDC5/irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity
Physical exercise is well known to benefit human health at every age. However, the exact mechanism through which physical exercise improves health remains unknown. Recent studies into exercise-induced myokine FNDC5/irisin, a newly discovered hormone, have begun to shed light on this mystery. Exercise-induced myokine FNDC5/irisin have been shown to be protective against cardiovascular damage post ischemic event, improve function in the neurons of Alzheimer’s disease patients, and have been implicated in macrophage and adipocyte regulation. Elegantly designed experiments have shown FNDC5/irisin to promote Nkx2.5+ cardiac progenitor cell dependent cardiac regeneration, neovascularization, and reduce cardiac fibrosis. It has also been shown to improve macrophage function, which may protect against injuries to the cardiac conduction system. Similarly, FNDC5/irisin knockout mice have been shown to have reduced memory performance, while peripheral overexpression of FNDC5/irisin has been shown to improve memory impairment in a murine Alzheimer’s disease model. Finally, FNDC5/irisin has been linked to regulation of osteocytes and adipocytes by signaling through the cytoplasmic membrane integrated protein aV/b5 integrin, the first known receptor for this newly discovered hormone. Although these recent discoveries have cemented the importance of FNDC5/irisin, many details regarding how FNDC5/irisin fits into the physiology of exercise benefits remain unknown and are deserving of future inquiry.
Routine physical exercise is well known to improve human health at every age. However, the molecular mechanism behind the benefits of exercise remains largely unclear. In recent years, a newly discovered hormone, FNDC5/irisin, became a promising target for the link between physical exercise and health [1, 2]. FNDC5/irisin is produced when exercise promotes splicing or cleaving of the myocyte extracellular domain fibronectin type III domain-containing protein 5 (FNDC5), a membrane integrated precursor protein controlled by myocyte peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α). Elevated levels of this exercise induced FNDC5/irisin has been linked to cardiovascular protection/repair and improved function in neurons of Alzheimer’s disease, with new findings hinting at involvement in osteocyte and adipocyte regulation.
Two independent clinical studies have cemented the protective effects of physical activity against cardiovascular disease (CVD) [3, 4]. In the PURE study, the incidences of and morality from myocardial infarction, stroke, and heart failure in a 130,000 cohort from 17 high-income, middle-income, and low-income countries was significantly lower in the group that engaged in regular physical activity. Interestingly, this study found no difference between recreational and non-recreational physical activity on the protective effect against CVD disease and mortality . Similarly, a second study on 487,000 Chinese men and women found physical activity to be equality effective between the sexes at preventing vascular events, including CVD, ischemic stroke, intracerebral hemorrhage, and deaths from vascular events . These findings have been further confirmed in multiple animal models. A mechanistic investigation has found FNDC5/irisin to promote cardiac regeneration, neovascularization, and reduce cardiac fibrosis by amplifying the ability of Nkx2.5+ cardiac progenitor cells (CPC) to repair cardiomyocytes and promote proliferation after an ischemic event . This protective effect has been shown to mediated by FNDC5/irisin induced up-regulation of proliferative markers Ki67 and phosphorylated histone 3 and marked reduction of histone deacetylase 4 and increased p38 acetylation in treated CPCs . FNDC5/irisin may also amplify healing by improving macrophage function through FNDC5/irisin triggered oxidization of low density lipoproteins via the endoplasmic reticulum stress pathway. This, in turn, maintains the cardiac conduction system as macrophage are known to facilitate electrical conduction and syncytium calcium signaling in the heart [6, 7, 8].
Analysis of Alzheimer disease (AD) patients and accompanying studies utilizing AD animal models also linked exercise-induced FNDC5/irisin to improved synaptic plasticity in symptomatic patients and animals . De Freitas and collogues first found FNDC5/irisin to be expressed in the hippocampus, cortex, and cerebrospinal fluid of wild-type C57BL/6 mice with lower levels found in AD mice. Wild-type mice with FNDC5/irisin knocked out in the brain using FNDC5/irisin-specific shRNA constructs showed impaired long-term potentiation, which led to poorer performance in novel object recognition, radial arm water maze, and contextual fear conditioning. Conversely, an intracerebroventricular infusion of FNDC5/irisin rescued memory impairment in AD mice. These findings were further proven by the ability to rescue memory impairment through peripheral overexpression of FNDC5/irisin and the ability to reduce the neuroprotectivity of physical exercise through the blockade of peripheral or brain FNDC5/irisin . This seminal paper was the first to demonstrate a mechanism behind the protective capacity of physical exercise in AD patients, which will indubitably inform future clinical approaches to maintain and rescue synaptic plasticity in AD patients.
XHX conceived of the study. XHX, XZ, MX, JLB and JM prepared the manuscript and edited the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
Consent for publication
Ethics approval and consent to participate
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Funding and acknowledgements
This work was supported by the NSFC (#31571273/31771277/31371256 to XHX), the Foreign Distinguished Scientist Program (#MS2014SXSF038), the National Department of Education Central Universities Research Fund (#GK20130100/201701005/GERP-17-45), US Maryland Stem Cell Research Fund (2009MSCRFE008300) and the Outstanding Doctoral Thesis fund (#X2014YB02/X2015YB05).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.